search
Back to results

A Controlled Study to Investigate the Effect of Multi-wave Light Emitting Diode (LED) Bed on Blood Pressure and Endothelial Function

Primary Purpose

Hypertension

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
LED bed
Sponsored by
LED Intellectual Properties, LLC
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Male or female of 18-75 years of age
  • If female, subject is not of child bearing potential
  • Subjects with seated resting systolic blood pressures between 130-160 mmHg and diastolic between 85-100 mmHg (inclusive) at screening visit
  • Subjects with mild to moderate endothelial dysfunction
  • Agreement to maintain current level of physical activity and diet throughout the study
  • Agrees to comply with study procedures including abstain from coffee at least 14 hours before blood pressure measurement and abstain from physical exercise at least 4 hours before blood pressure measurement
  • Has given voluntary, written, and informed consent to participate in the study

Exclusion Criteria:

  • Females who are pregnant, breastfeeding, or planning to become pregnant during the course of the study
  • Seated office systolic blood pressure outside of the target range (systolic blood pressure <130 mmHg or >160 mmHg) or diastolic blood pressure <85 or >100 mmHg at screening
  • The use of natural health products for the treatment of hypertension within 2 weeks of screening
  • Significant cardiac history defined as a history of myocardial infarction (MI); coronary angioplasty or bypass graft(s); Valvular disease or repair; unstable angina pectoris; transient ischemic attack (TIA); cerebrovascular accidents (CVA); congestive heart failure; or coronary artery disease (CAD)
  • Type I diabetes
  • Unstable medical conditions that in the opinion of the Principle Investigator preclude the subject from participating in the study
  • Alcohol or drug abuse within the last 6 months
  • Participation in a clinical research trial within 30 days prior to randomization
  • Individuals who are cognitively impaired and/or who are unable to give informed consent
  • Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject

Sites / Locations

  • Nitric Oxide InnovationsRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

LightStim LED Bed

Arm Description

Full body LED bed device.

Outcomes

Primary Outcome Measures

Hypertension
The primary efficacy outcome to be analyzed is the between-group changes from baseline (Day 0) to end of study (Day 60) in daytime mean systolic and diastolic BP and endothelial function, measured using a triplicate readings using AHA guidelines and MaxPulse, respectively.

Secondary Outcome Measures

Full Information

First Posted
June 29, 2019
Last Updated
July 1, 2019
Sponsor
LED Intellectual Properties, LLC
search

1. Study Identification

Unique Protocol Identification Number
NCT04006158
Brief Title
A Controlled Study to Investigate the Effect of Multi-wave Light Emitting Diode (LED) Bed on Blood Pressure and Endothelial Function
Official Title
A Controlled Study to Investigate the Effect of a Multi-wave Light Emitting Diode (LED) Bed on Blood Pressure and Endothelial Function
Study Type
Interventional

2. Study Status

Record Verification Date
June 2019
Overall Recruitment Status
Unknown status
Study Start Date
August 29, 2018 (Actual)
Primary Completion Date
December 31, 2020 (Anticipated)
Study Completion Date
December 31, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
LED Intellectual Properties, LLC

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of this multi-center study is to investigate the effect of a multi-wave LED light bed on blood pressure and endothelial function in pre-hypertensive and mildly hypertensive adults.
Detailed Description
Subjects will be instructed to lay in the bed for 20 minutes on their stomach followed by 20 minutes on their back for a total of 40 minutes three times per week for 8 weeks. Subjects will be instructed to begin light treatment on Day 1 after baseline measurements have been collected. Subjects will be required to visit a Wellness Center of Dr. Bryan or Hypertension Institute in Nashville, informed of the study and if agreed will sign the consent form. After consent, subjects will be required to spend about 30 minutes to get baseline measurements. Subjects will then be required to lie in bed for 40 minutes each day three days per week for 8 weeks. Blood pressure and endothelial function tests will be recorded at baseline and after each light treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
LightStim LED Bed
Arm Type
Experimental
Arm Description
Full body LED bed device.
Intervention Type
Device
Intervention Name(s)
LED bed
Intervention Description
Low risk FDA cleared full body LED bed
Primary Outcome Measure Information:
Title
Hypertension
Description
The primary efficacy outcome to be analyzed is the between-group changes from baseline (Day 0) to end of study (Day 60) in daytime mean systolic and diastolic BP and endothelial function, measured using a triplicate readings using AHA guidelines and MaxPulse, respectively.
Time Frame
8 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Male or female of 18-75 years of age If female, subject is not of child bearing potential Subjects with seated resting systolic blood pressures between 130-160 mmHg and diastolic between 85-100 mmHg (inclusive) at screening visit Subjects with mild to moderate endothelial dysfunction Agreement to maintain current level of physical activity and diet throughout the study Agrees to comply with study procedures including abstain from coffee at least 14 hours before blood pressure measurement and abstain from physical exercise at least 4 hours before blood pressure measurement Has given voluntary, written, and informed consent to participate in the study Exclusion Criteria: Females who are pregnant, breastfeeding, or planning to become pregnant during the course of the study Seated office systolic blood pressure outside of the target range (systolic blood pressure <130 mmHg or >160 mmHg) or diastolic blood pressure <85 or >100 mmHg at screening The use of natural health products for the treatment of hypertension within 2 weeks of screening Significant cardiac history defined as a history of myocardial infarction (MI); coronary angioplasty or bypass graft(s); Valvular disease or repair; unstable angina pectoris; transient ischemic attack (TIA); cerebrovascular accidents (CVA); congestive heart failure; or coronary artery disease (CAD) Type I diabetes Unstable medical conditions that in the opinion of the Principle Investigator preclude the subject from participating in the study Alcohol or drug abuse within the last 6 months Participation in a clinical research trial within 30 days prior to randomization Individuals who are cognitively impaired and/or who are unable to give informed consent Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nathan S Bryan, Ph.D.
Phone
512-773-9097
Email
drnathanbryan@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Chase Marchese
Phone
714-924-0492
Email
chase@lightstim.com
Facility Information:
Facility Name
Nitric Oxide Innovations
City
Rockdale
State/Province
Texas
ZIP/Postal Code
76567
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nathan S Bryan, Ph.D.
Phone
512-773-9097
Email
drnathanbryan@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

A Controlled Study to Investigate the Effect of Multi-wave Light Emitting Diode (LED) Bed on Blood Pressure and Endothelial Function

We'll reach out to this number within 24 hrs